Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer

Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

E Amir, R Broom, O Freedman, WS Ooi, S Done, D Gianfelice, D Barth, H Kahn and M Clemons

Breast Cancer Research 2009, 11(Suppl 1):P27 doi:10.1186/bcr2310

Accesses  

  • Last 30 days: 12 accesses
  • Last 365 days: 149 accesses
  • All time: 578 accesses